• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胰腺癌中上调并促进癌细胞增殖且抑制细胞凋亡。

is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis.

作者信息

Qin Jing, Wang Wangsheng, An Fangmei, Huang Wei, Ding Junli

机构信息

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, P.R. China.

Department of Oncology, Wuxi Hospital of traditional Chinese Medicine, Wuxi, 214071, P.R. China.

出版信息

J Cancer. 2019 Aug 27;10(20):4939-4946. doi: 10.7150/jca.27616. eCollection 2019.

DOI:10.7150/jca.27616
PMID:31598166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6775526/
Abstract

: The lack of effective therapeutic targets poses a leading challenge to prolong survival and improve the quality of life for pancreatic cancer patients. Proteasome 26S subunit ATPase 2 (), a recently discovered gene, has been implicated in certain human carcinogenesis. However, limited data is available concerning the functional significance of in cancer cell growth, and whether it plays a role in pancreatic carcinogenesis remains unknown. : Quantitative RT-PCR (qRT-PCR) was performed to assess mRNA expression levels of in different pancreatic cancer cell lines. Knockdown of was achieved by using short hairpin RNA (shRNA). The effects of silencing on pancreatic cancer cell proliferation and apoptosis were evaluated by the MTT cell proliferation assay, Celigoassays, Annexin V fluorescence-activated cell sorting (FACS) assay and Caspase-3/7 array. : High expression of was detected in three pancreatic cancer cell lines (SW1990, PANC-1, and AsPC-1). Knockdown of in SW1990 cells inhibited proliferation and enhanced apoptosis. : Our primary study suggests that might be involved in the progression of pancreatic cancer and may serve as a potential therapeutic target.

摘要

缺乏有效的治疗靶点是延长胰腺癌患者生存期和提高其生活质量面临的主要挑战。蛋白酶体26S亚基ATP酶2( )是最近发现的一个基因,已被证明与某些人类癌症发生有关。然而,关于 在癌细胞生长中的功能意义的数据有限,其是否在胰腺癌发生中起作用仍不清楚。:采用定量逆转录聚合酶链反应(qRT-PCR)评估 在不同胰腺癌细胞系中的mRNA表达水平。通过使用短发夹RNA(shRNA)实现 的敲低。通过MTT细胞增殖试验、Celigo试验、膜联蛋白V荧光激活细胞分选(FACS)试验和Caspase-3/7阵列评估 沉默对胰腺癌细胞增殖和凋亡的影响。:在三种胰腺癌细胞系(SW1990、PANC-1和AsPC-1)中检测到 的高表达。SW1990细胞中 的敲低抑制了增殖并增强了凋亡。:我们的初步研究表明, 可能参与胰腺癌的进展,并可能作为一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/de0504f01d42/jcav10p4939g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/020ae0e5e28a/jcav10p4939g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/cb1dc56d1074/jcav10p4939g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/3af02d1556c1/jcav10p4939g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/f7f5d4dbaf15/jcav10p4939g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/de0504f01d42/jcav10p4939g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/020ae0e5e28a/jcav10p4939g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/cb1dc56d1074/jcav10p4939g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/3af02d1556c1/jcav10p4939g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/f7f5d4dbaf15/jcav10p4939g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99c7/6775526/de0504f01d42/jcav10p4939g005.jpg

相似文献

1
is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis.在胰腺癌中上调并促进癌细胞增殖且抑制细胞凋亡。
J Cancer. 2019 Aug 27;10(20):4939-4946. doi: 10.7150/jca.27616. eCollection 2019.
2
Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.蛋白酶体 26S 亚基 ATP 酶 2 的沉默调节结直肠癌细胞的增殖、凋亡和迁移。
Chemotherapy. 2019;64(3):146-154. doi: 10.1159/000502224. Epub 2019 Nov 12.
3
Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration.PSMC2基因沉默通过调控增殖、凋亡和迁移来抑制前列腺癌的发展和转移。
Cancer Cell Int. 2021 Apr 26;21(1):235. doi: 10.1186/s12935-021-01934-8.
4
PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma.PSMC2通过p21/细胞周期蛋白D1途径调控细胞周期进程,并预测人类肝细胞癌的不良预后。
Front Oncol. 2021 Feb 26;11:607021. doi: 10.3389/fonc.2021.607021. eCollection 2021.
5
PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.PSMC2 在神经胶质瘤中过表达,促进神经胶质瘤细胞的增殖和抗凋亡。
World J Surg Oncol. 2022 Mar 14;20(1):84. doi: 10.1186/s12957-022-02533-1.
6
Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).PSMC2 的过表达通过调节尿激酶型纤溶酶原激活物(PLAU)促进人乳腺癌的发生和发展。
Cell Death Dis. 2021 Jul 9;12(7):690. doi: 10.1038/s41419-021-03960-w.
7
Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.miR-630 表达水平降低预示着骨肉瘤预后不良,并通过靶向 PSMC2 促进细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1915-1925. doi: 10.26355/eurrev_201903_17229.
8
[MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].[微小RNA-150-5p抑制胰腺癌细胞增殖并促进其凋亡]
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):460-4. doi: 10.3760/cma.j.issn.0529-5807.2013.07.007.
9
PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway.PSMC2通过诱导RPS15A/mTOR通路促进胃癌进展。
Oncogenesis. 2022 Mar 7;11(1):12. doi: 10.1038/s41389-022-00386-7.
10
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer.PSMC2是一种新型预后生物标志物并可预测免疫治疗反应:从胰腺癌到泛癌
Pharmgenomics Pers Med. 2023 Aug 9;16:747-758. doi: 10.2147/PGPM.S418533. eCollection 2023.

引用本文的文献

1
Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.蛋白酶体26S亚基ATP酶家族基因作为肝细胞癌潜在预后生物标志物和治疗靶点的研究
Cancer Manag Res. 2024 Feb 13;16:95-111. doi: 10.2147/CMAR.S449488. eCollection 2024.
2
Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.迈向精准肿瘤学发现:四个鲜为人知的基因及其未知相互作用作为结直肠癌的高效生物标志物
NPJ Precis Oncol. 2024 Jan 20;8(1):13. doi: 10.1038/s41698-024-00512-1.
3

本文引用的文献

1
Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells.高三尖杉酯碱可通过激活 MEK1/ERK1/2 信号通路诱导胰腺癌细胞中 PSMD11 的快速蛋白合成。
J Cell Biochem. 2018 Aug;119(8):6644-6656. doi: 10.1002/jcb.26847. Epub 2018 Apr 17.
2
Proteasomes beyond proteolysis: Roles in heterochromatin maintenance.蛋白酶体的蛋白水解功能之外:在异染色质维持中的作用
J Biol Chem. 2017 Oct 13;292(41):17156-17157. doi: 10.1074/jbc.H117.790824.
3
Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis.
PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
PSMC2基因敲低通过调节AKT信号通路在鼻咽癌中发挥抗肿瘤作用。
Cell Cycle. 2023 Nov;22(21-22):2381-2391. doi: 10.1080/15384101.2023.2293590. Epub 2024 Jan 18.
4
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer.PSMC2是一种新型预后生物标志物并可预测免疫治疗反应:从胰腺癌到泛癌
Pharmgenomics Pers Med. 2023 Aug 9;16:747-758. doi: 10.2147/PGPM.S418533. eCollection 2023.
5
Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.泛癌分析确定了蛋白酶体26S亚基、ATP酶(PSMC)家族基因,以及与肺腺癌预后、免疫特征和治疗反应相关的特征。
Front Genet. 2023 Jan 9;13:1017866. doi: 10.3389/fgene.2022.1017866. eCollection 2022.
6
PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy.PSME2可识别乳腺癌中的免疫热肿瘤,并与免疫治疗的良好疗效相关。
Front Genet. 2022 Dec 13;13:1071270. doi: 10.3389/fgene.2022.1071270. eCollection 2022.
7
Evaluating the Prognostic and Therapeutic Potentials of the Proteasome 26S Subunit, ATPase () Family of Genes in Lung Adenocarcinoma: A Database Mining Approach.评估蛋白酶体26S亚基ATP酶()基因家族在肺腺癌中的预后和治疗潜力:一种数据库挖掘方法。
Front Genet. 2022 Jul 22;13:935286. doi: 10.3389/fgene.2022.935286. eCollection 2022.
8
PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.PSMC2 在神经胶质瘤中过表达,促进神经胶质瘤细胞的增殖和抗凋亡。
World J Surg Oncol. 2022 Mar 14;20(1):84. doi: 10.1186/s12957-022-02533-1.
9
PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway.PSMC2通过诱导RPS15A/mTOR通路促进胃癌进展。
Oncogenesis. 2022 Mar 7;11(1):12. doi: 10.1038/s41389-022-00386-7.
10
PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.PSMC2 敲低通过激活 PI3K/Akt 通路促进细胞凋亡抑制口腔鳞状细胞癌的进展。
Cell Cycle. 2022 Mar;21(5):477-488. doi: 10.1080/15384101.2021.2021722. Epub 2022 Jan 4.
泛素-蛋白酶体系统对参与胰腺癌发生的一种进化保守的RNA聚合酶II相关因子1的调控
Biochemistry. 2017 Nov 21;56(46):6083-6086. doi: 10.1021/acs.biochem.7b00865. Epub 2017 Oct 19.
4
The 19S proteasome is directly involved in the regulation of heterochromatin spreading in fission yeast.19S蛋白酶体直接参与裂殖酵母中异染色质扩散的调控。
J Biol Chem. 2017 Oct 13;292(41):17144-17155. doi: 10.1074/jbc.M117.790824. Epub 2017 Aug 7.
5
Long-range allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs.长程别构调控人类 26S 蛋白酶体由 20S 蛋白酶体靶向抗癌药物。
Nat Commun. 2017 May 25;8:15578. doi: 10.1038/ncomms15578.
6
PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.PSMC2在骨肉瘤中上调,并调节骨肉瘤细胞的增殖、凋亡和迁移。
Oncotarget. 2017 Jan 3;8(1):933-953. doi: 10.18632/oncotarget.13511.
7
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
8
The 26S proteasome is a multifaceted target for anti-cancer therapies.26S蛋白酶体是抗癌疗法的一个多方面的靶点。
Oncotarget. 2015 Sep 22;6(28):24733-49. doi: 10.18632/oncotarget.4619.
9
Whole genomes redefine the mutational landscape of pancreatic cancer.全基因组重新定义了胰腺癌的突变格局。
Nature. 2015 Feb 26;518(7540):495-501. doi: 10.1038/nature14169.
10
A comparative genomic approach for identifying synthetic lethal interactions in human cancer.一种用于鉴定人类癌症中合成致死相互作用的比较基因组方法。
Cancer Res. 2013 Oct 15;73(20):6128-36. doi: 10.1158/0008-5472.CAN-12-3956. Epub 2013 Aug 26.